| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Elliot P. Joslin Laboratory (N.A.T., J.W.M., E.M.-F.), Joslin Diabetes Center, Division of Endocrinology (J.K.E., J.S.F.) and Department of Neurology (J.K.E.), Beth Israel Deaconess Medical Center, Program in Neuroscience (J.K.E.), Harvard Medical School, Boston, Massachusetts 02215
Address all correspondence and requests for reprints to: Eleftheria Maratos-Flier, M.D., Joslin Diabetes Center, Room 620, One Joslin Place, Boston, Massachusetts 02215. E-mail: emarat{at}joslab.harvard.edu
Brown adipose tissue-deficient [uncoupling protein (UCP)-promoter-driven diphtheria toxin A (DTA)] mice develop obesity as a result of both decreased energy expenditure and hyperphagia. The hyperphagia occurs despite high serum leptin levels. Hence, this is a model of leptin-resistant obesity in which the mechanism driving hyperphagia is unknown. Leptin is a regulator of a number of hypothalamic neuropeptides involved in energy homeostasis. In ob/ob mice, leptin deficiency results in increased expression of neuropeptide Y (NPY), agouti-related protein (AGRP), and melanin-concentrating hormone (MCH), and decreased expression of POMC. We have previously shown that NPY is reduced in the UCP-DTA mouse, suggesting a normal NPY response to leptin. To define other potential sites of leptin resistance, we used in situ hybridization to evaluate the expression of messenger RNAs (mRNAs) encoding a number of peptides, including NPY, AGRP, MCH, and POMC. We confirmed that the decrease in NPY expression previously detected by Northern blots reflects a decrease in NPY expression in the arcuate nucleus. AGRP mRNA was also decreased, whereas POMC mRNA levels in the arcuate nucleus were the same as control. MCH mRNA levels in the lateral hypothalamic area were also decreased. In contrast, there was induction of NPY expression in the dorsomedial hypothalamic nucleus in the UCP-DTA animals but not in the controls. The results indicate that these neuropeptides generally respond to leptin and that the hyperphagia seen in the UCP-DTA mice is likely the result of dysregulated expression of other, as yet unexamined, hypothalamic peptides, or lies at sites distal to the hypothalamus.
This article has been cited by other articles:
![]() |
N. S. Singhal, M. A. Lazar, and R. S. Ahima Central Resistin Induces Hepatic Insulin Resistance via Neuropeptide Y J. Neurosci., November 21, 2007; 27(47): 12924 - 12932. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pissios, U. Ozcan, E. Kokkotou, T. Okada, C. W. Liew, S. Liu, J. N. Peters, G. Dahlgren, J. Karamchandani, Y. C. Kudva, et al. Melanin Concentrating Hormone Is a Novel Regulator of Islet Function and Growth Diabetes, February 1, 2007; 56(2): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Patel, Y. Qi, E. J. Hawkins, S. M. Hileman, J. K. Elmquist, Y. Imai, and R. S. Ahima Neuropeptide Y Deficiency Attenuates Responses to Fasting and High-Fat Diet in Obesity-Prone Mice Diabetes, November 1, 2006; 55(11): 3091 - 3098. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Javor, E. K. Cochran, C. Musso, J. R. Young, A. M. DePaoli, and P. Gorden Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy Diabetes, July 1, 2005; 54(7): 1994 - 2002. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bi, K. A. Scott, J. Hyun, E. E. Ladenheim, and T. H. Moran Running Wheel Activity Prevents Hyperphagia and Obesity in Otsuka Long-Evans Tokushima Fatty Rats: Role of Hypothalamic Signaling Endocrinology, April 1, 2005; 146(4): 1676 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Tallam, J. J. Kuo, A. A. da Silva, and J. E. Hall Cardiovascular, Renal, and Metabolic Responses to Chronic Central Administration of Agouti-Related Peptide Hypertension, December 1, 2004; 44(6): 853 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bi, B. M. Robinson, and T. H. Moran Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1030 - R1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Baran, E. Preston, D. Wilks, G. J. Cooney, E. W. Kraegen, and A. Sainsbury Chronic Central Melanocortin-4 Receptor Antagonism and Central Neuropeptide-Y Infusion in Rats Produce Increased Adiposity by Divergent Pathways Diabetes, January 1, 2002; 51(1): 152 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rios, G. Fan, C. Fekete, J. Kelly, B. Bates, R. Kuehn, R. M. Lechan, and R. Jaenisch Conditional Deletion Of Brain-Derived Neurotrophic Factor in the Postnatal Brain Leads to Obesity and Hyperactivity Mol. Endocrinol., October 1, 2001; 15(10): 1748 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bi, E. E. Ladenheim, G. J. Schwartz, and T. H. Moran A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R254 - R260. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hagan, P. A. Rushing, S. C. Benoit, S. C. Woods, and R. J. Seeley Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R814 - R821. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Inui Transgenic Approach to the Study of Body Weight Regulation Pharmacol. Rev., March 1, 2000; 52(1): 35 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Ahima, J. Kelly, J. K. Elmquist, and J. S. Flier Distinct Physiologic and Neuronal Responses to Decreased Leptin and Mild Hyperleptinemia Endocrinology, November 1, 1999; 140(11): 4923 - 4931. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |